San Diego, CA, United States of America

Douglas Cruise


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal3 out of 832,843 
Other
 patents

Years Active: 2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Douglas Cruise: Innovator in Pharmaceutical Chemistry

Introduction

Douglas Cruise is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug compounds. With a total of 3 patents, his work has had a meaningful impact on the industry.

Latest Patents

One of his latest patents is the synthesis of the PARP inhibitor talazoparib. This patent provides a new method for preparing this important compound, which is crucial in cancer treatment. Another significant patent involves the process of preparing (E)-3-(4-methoxyphenyl)-N-methyl-N-((6,7,8,9-tetrahydro-5H-benzo-[7]annulen-2-yl)methyl)prop-2-en-1-amine. This patent outlines a new method for preparing this compound as a drug intermediate, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Throughout his career, Douglas has focused on creating effective solutions in drug synthesis. His expertise in this area has led to the successful development of multiple patents that contribute to advancements in medicine. His work is characterized by a commitment to improving therapeutic options for patients.

Collaborations

Douglas has collaborated with talented individuals in his field, including Yong Xu and Peter W Yohi. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

In summary, Douglas Cruise is a distinguished inventor whose work in pharmaceutical chemistry has resulted in valuable patents and innovative drug synthesis methods. His contributions continue to influence the field and improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…